Mesane kanserli hastalarda HLA sınıf I (A ve B) ve II (DR) allelleri sıklığı
The frequency of HLA class I (A and B) and class II (DR) alleles in patients with bladder cancer
- Tez No: 171641
- Danışmanlar: PROF.DR. BÜLENT ALAGÖL
- Tez Türü: Tıpta Uzmanlık
- Konular: Üroloji, Urology
- Anahtar Kelimeler: Bladder cancers, genetics, HLA 46, Bladder cancers, genetics, HLA 46
- Yıl: 2006
- Dil: Türkçe
- Üniversite: Trakya Üniversitesi
- Enstitü: Tıp Fakültesi
- Ana Bilim Dalı: Üroloji Ana Bilim Dalı
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: Belirtilmemiş.
Özet
with primarily bladder cancer HLA B*15 allele and in patients with recurrent bladder cancer HLA DR*13 allele were higher, but not significant statistically.
Özet (Çeviri)
THE FREQUENCY OF HLA CLASS I (A AND B) AND CLASS II (DR) ALLELES IN PATIENTS WITH BLADDER CANCER SUMMARY There are so many etiologic factors performed in the bladder cancer, which is the second most common urologic cancer. In the different races and nations who exposure the similar factors, it has not seen in the same incidence. This difference has evoked the probability of relation with bladder cancers and human leukocyte antigens system that is the genetic identity of races and nations and located in the major histocompatibility complex region of 6th chromosome's short arm. In our study, the frequency of HLA class I (A and B) and class II (DR) alleles of 27 patients with histologically proven urothelial bladder cancer who were living in Trakya region since last three generation was compared with the frequency of HLA class I (A and B) and class II (DR) alleles of 67 healthy volunteers who were also living in Trakya region since last three generation. Typing of HLA was performed by using the low resolution molecular genetic techniques. Statistical analysis was made by using the Chi-square test. In our study, it was determined that HLA A*31, HLA B*15 and HLA B*18 alleles can be facilitative for bladder cancers. There was no protective HLA allele for bladder cancers. In patients with invasive bladder cancer HLA A*1 and HLA DR*4 alleles, in patients with low grade bladder cancer HLA A*26 and HLA B*15 alleles, in patients with high grade bladder cancer HLA A*1 and HLA DR*13 alleles, in patients 45with primarily bladder cancer HLA B*15 allele and in patients with recurrent bladder cancer HLA DR*13 allele were higher, but not significant statistically.
Benzer Tezler
- Mesane kanserli hastalarda klinik progresyonu ve kemoterapiye olan yanıtı değerlendirmede periferik kan lenfosit alt gruplarının flowsitometrik analizinin değeri
The Value of flowcytometric analyses of peripheral blood lymphocyte subsets to evaluate the clinical progression and response to chemotherapy in bladder transitional cell carcinoma
Y. TARKAN SOYGÜR
- Mesane kanserli hastalarda üriner glikozaminoglikan seviyeleri
Başlık çevirisi yok
HAKAN KILIÇARSLAN
Tıpta Uzmanlık
Türkçe
1999
ÜrolojiCumhuriyet ÜniversitesiÜroloji Ana Bilim Dalı
PROF. DR. E. YENER GÜLTEKİN
- Mesane kanserli hastalarda Metil guanin DNA metil transferaz aktivitesi, glutatyon S transferaz ve nitrik oksit'in önemi
Methyl guanine DNA methyl transferase(MGMT) activities, Glutathione S transferases (GST) and Nitric Oxide (NO) in bladder cancer patients
EYÜP İLKER SAYGILI
- Mesane kanserli hastalarda risk kontrolu sorgulamasının (Risikocheck) prognostik önemi
Mesane kanserli hastalarda risk kontrolu sorgulamasının (Risikocheck) prognostik önemi
ABDÜLKADİR YILDIZ
Tıpta Uzmanlık
Türkçe
2010
ÜrolojiZonguldak Karaelmas ÜniversitesiÜroloji Ana Bilim Dalı
PROF. DR. N.AYDIN MUNGAN
- Mesane kanserli hastalarda kromozom 4q22-35 bölgesindeki heterozigotluk kayıplarının araştırılması
Investigation of loss of heterozygosity on chromosome 4q22-35 region in patients with bladder cancer
ÇİĞDEM TAŞ
Yüksek Lisans
Türkçe
2011
BiyolojiGaziantep ÜniversitesiBiyoloji Ana Bilim Dalı
PROF. DR. MEHMET ÖZASLAN
YRD. DOÇ. DR. BEYHAN CENGİZ